As such, resilient individuals retain cognitive fitness in the face of marked Aβ and tau deposition, whereas frail individuals experience chronic cognitive decline despite lack of AD or other gross neuropathology on autopsy. The gene discussed is MAPT; the disease is Alzheimer disease.